Publication | Closed Access
Oral l‐ornithine‐l‐aspartate in minimal hepatic encephalopathy: A randomized, double‐blind, placebo‐controlled trial
59
Citations
17
References
2013
Year
A 60-day oral LOLA course was not better than placebo in treating MHE, but was useful in preventing further episodes of OHE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1